Literature DB >> 33553029

Mormodica charantia L. fruit and Genistein ameliorates type 2 diabetes in rats by preventing lipid accumulation, insulin resistance and enhancing beta cell function.

Wusa Makena1,2, Joseph O Hambolu3, James A Timbuak4, Uduak E Umana1, Abdullahi I Iliya5, Nathan I Dibal2.   

Abstract

PURPOSE: The present study was aimed at evaluating the role of Momordica charantia L. fruit and Genistein on beta cell, insulin resistance/sensitivity and lipid profile in type 2 diabetic rats.
METHODS: Thirty-five (35) albino rats were divided into seven (7) groups of 5 rats each comprising of five (5) non-diabetic and thirty (30) diabetic rats. Groups 1 and 2 served as the normal control and diabetic control groups respectively and received distill water, groups 3 and 4 received Mormodica charantia L. at 250 mg/kg and 500 mg/kg respectively. Groups 5 and 6 received Genistein at 10 mg/kg and 20 mg/kg respectively while group 7 received Metformin at 500 mg/kg the experiment lasted for four weeks. All the rats were euthanized at the end of the fourth week.
RESULTS: Lipid profile, glucose and insulin levels were determined from the analysis of serum parameters and the histology of the pancreas. A significant reduction (p < 0.05) in blood glucose levels was noticed in rats that received Momordica charantia L. (MC) and genistein when compared with diabetic control rats. A significant decrease (p < 0.05) in cholesterol, triglyceride, low density lipoprotein (LDL) and very low density lipoprotein (VLDL) levels were also noted in rats that received MC and Genistein when compared with the diabetic control rats. MC and Genistein significantly increased (P < 0.05) serum insulin level compared to the diabetic control rats. MC and Genistein significantly decreased (p < 0.05) homeostatic model assessment-insulin resistance (HOMA-IR) level compared with the diabetic control group. Pancreas of rats that received MC and Genistein showed regenerating beta-cells.
CONCLUSION: Momordica charantia L. fruit and Genistein were able to enhance beta cell function and prevent lipid accumulation and insulin resistance in type 2 diabetic rats. © Springer Nature Switzerland AG 2020.

Entities:  

Keywords:  Glucose; Hyperglycemia; Insulin; Isoflavones; Momordin; Pancreas

Year:  2020        PMID: 33553029      PMCID: PMC7843820          DOI: 10.1007/s40200-020-00648-4

Source DB:  PubMed          Journal:  J Diabetes Metab Disord        ISSN: 2251-6581


  49 in total

Review 1.  Obesity and insulin resistance.

Authors:  B B Kahn; J S Flier
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

2.  Phenolic contents and antioxidant activities of bitter gourd (Momordica charantia L.) leaf, stem and fruit fraction extracts in vitro.

Authors:  Jittawan Kubola; Sirithon Siriamornpun
Journal:  Food Chem       Date:  2008-03-04       Impact factor: 7.514

3.  Increased hepatic Fatty Acid uptake and esterification contribute to tetracycline-induced steatosis in mice.

Authors:  You-Jin Choi; Chae-Hyeon Lee; Kang-Yo Lee; Seung-Hwan Jung; Byung-Hoon Lee
Journal:  Toxicol Sci       Date:  2015-03-04       Impact factor: 4.849

4.  Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition.

Authors:  Pouya Saeedi; Inga Petersohn; Paraskevi Salpea; Belma Malanda; Suvi Karuranga; Nigel Unwin; Stephen Colagiuri; Leonor Guariguata; Ayesha A Motala; Katherine Ogurtsova; Jonathan E Shaw; Dominic Bright; Rhys Williams
Journal:  Diabetes Res Clin Pract       Date:  2019-09-10       Impact factor: 5.602

Review 5.  Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The Claude Bernard Lecture 2009.

Authors:  R A DeFronzo
Journal:  Diabetologia       Date:  2010-04-02       Impact factor: 10.122

6.  Haematological parameters and lipid profile abnormalities among patients with Type-2 diabetes mellitus in Ghana.

Authors:  Samuel Antwi-Baffour; Ransford Kyeremeh; Samuel Owusu Boateng; Lawrence Annison; Mahmood Abdulai Seidu
Journal:  Lipids Health Dis       Date:  2018-12-13       Impact factor: 3.876

7.  The Effects of Soy Protein and Cocoa With or Without Isoflavones on Glycemic Control in Type 2 Diabetes. A Double-Blind, Randomized, Placebo-Controlled Study.

Authors:  Judit Konya; Thozhukat Sathyapalan; Eric S Kilpatrick; Stephen L Atkin
Journal:  Front Endocrinol (Lausanne)       Date:  2019-05-09       Impact factor: 5.555

8.  Therapeutic effects of balanitoside in streptozotocin-induced diabetic rats.

Authors:  Wusa Makena; Wilson O Hamman; Adebayo A Buraimoh; Nathan I Dibal; Sunday G Obaje
Journal:  J Taibah Univ Med Sci       Date:  2018-02-09

9.  Insulin resistance and systemic metabolic changes in oral glucose tolerance test in 5340 individuals: an interventional study.

Authors:  Qin Wang; Jari Jokelainen; Juha Auvinen; Katri Puukka; Sirkka Keinänen-Kiukaanniemi; Marjo-Riitta Järvelin; Johannes Kettunen; Ville-Petteri Mäkinen; Mika Ala-Korpela
Journal:  BMC Med       Date:  2019-11-29       Impact factor: 8.775

10.  Type 2 diabetes is associated with loss of HDL endothelium protective functions.

Authors:  Tomáš Vaisar; Erica Couzens; Arnold Hwang; Michael Russell; Carolyn E Barlow; Laura F DeFina; Andrew N Hoofnagle; Francis Kim
Journal:  PLoS One       Date:  2018-03-15       Impact factor: 3.240

View more
  3 in total

Review 1.  Genistein-Opportunities Related to an Interesting Molecule of Natural Origin.

Authors:  Ewa Garbiec; Judyta Cielecka-Piontek; Magdalena Kowalówka; Magdalena Hołubiec; Przemysław Zalewski
Journal:  Molecules       Date:  2022-01-26       Impact factor: 4.411

Review 2.  Natural Polyphenols in Metabolic Syndrome: Protective Mechanisms and Clinical Applications.

Authors:  Shiyao Zhang; Mengyi Xu; Wenxiang Zhang; Chang Liu; Siyu Chen
Journal:  Int J Mol Sci       Date:  2021-06-06       Impact factor: 5.923

Review 3.  Herbal Medicines Targeting the Improved β-Cell Functions and β-Cell Regeneration for the Management of Diabetes Mellitus.

Authors:  Akurange Sujeevi Dammadinna Wickramasinghe; Pabasara Kalansuriya; Anoja Priyadarshani Attanayake
Journal:  Evid Based Complement Alternat Med       Date:  2021-07-14       Impact factor: 2.629

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.